Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study

Usharani Pingali, Mohammed Abid Ali, Srinivas Gundagani, Chandrasekhar Nutalapati Department of Pharmacology and Therapeutics, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana 500073, IndiaCorrespondence: Usharani Pingali Email ushapingali@yahoo.comPurpose: Neem tree (Azadiracht...

Full description

Bibliographic Details
Main Authors: Pingali U, Ali MA, Gundagani S, Nutalapati C
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/evaluation-of-the-effect-of-an-aqueous-extract-of-azadirachta-indica-n-peer-reviewed-article-DMSO
_version_ 1797936142284226560
author Pingali U
Ali MA
Gundagani S
Nutalapati C
author_facet Pingali U
Ali MA
Gundagani S
Nutalapati C
author_sort Pingali U
collection DOAJ
description Usharani Pingali, Mohammed Abid Ali, Srinivas Gundagani, Chandrasekhar Nutalapati Department of Pharmacology and Therapeutics, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana 500073, IndiaCorrespondence: Usharani Pingali Email ushapingali@yahoo.comPurpose: Neem tree (Azadirachta indica) offers different bioactives ranging from pesticides to therapeutic molecules, depending on which part of the plant is used and the extraction methodology and the solvent used. This study was aimed at evaluating the safety and efficacy of a standardized aqueous extract of Azadirachta indica leaves and twigs (NEEM) on glycemic control, endothelial dysfunction, and systemic inflammation in patients with type 2 diabetes mellitus (T2DM).Methods: In this randomized, double-blind, placebo-controlled clinical study (RCT), 80 T2DM subjects, who have already been on standard metformin therapy, received either 125 mg, 250 mg, 500 mg of NEEM or placebo twice daily for 12 weeks. Postprandial blood sugar level (PPBS), fasting blood sugar level (FBS), glycosylated hemoglobin (HbA1c), insulin resistance (IR), endothelial function, oxidative stress, systemic inflammation, IL-6 and TNF-α, platelet aggregation and lipid profile were assessed. Adverse drug reactions, if any, were noted. GraphPad Prism 8 was used to perform statistical analysis.Results: NEEM at the doses of 125, 250, and 500 mg BID significantly reduced PPBS (from 194.4± 14 to 173.1± 12.8mg/dL, 192.3± 17.1 to 161.8± 9.7mg/dL, and 205.9± 7.2 to 159.3± 7.1mg/dL, respectively), FBS (from 119.2± 5.0 to 109.2± 5.7mg/dL, 115.5± 4.4 to 103.7± 4.2mg/dL, and 120.7± 4.2 to 97.3± 3.7mg/dL, respectively), HbA1c (from 6.87 ± 0.4% to 6.64 ± 0.4%, 7.52 ± 0.4% to 6.86 ± 0.3%, and 7.78 ± 0.2% to 6.26 ± 0.4%, respectively), and IR (from 4.5 ± 1.2 to 3.4 ± 0.9, 3.8 ± 1.1 to 2.5 ± 0.6, and 4.6 ± 1.3 to 2.0 ± 0.6, respectively) compared to placebo. Also, NEEM significantly improved endothelial function, decreased oxidative stress and systemic inflammation compared to placebo. The efficacy was significant with all the doses, but no effect on platelet aggregation or lipid profile was observed.Conclusion: NEEM may significantly ameliorate hyperglycemia, endothelial dysfunction, and systemic inflammation, on top of what metformin could do, in subjects with T2DM.Keywords: Azadirachta indica, neem, hyperglycemia, insulin resistance, endothelial dysfunction, type 2 diabetes, metformin
first_indexed 2024-04-10T18:26:10Z
format Article
id doaj.art-f969db130cfa4b878d2ae8a6dee0b9a8
institution Directory Open Access Journal
issn 1178-7007
language English
last_indexed 2024-04-10T18:26:10Z
publishDate 2020-11-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj.art-f969db130cfa4b878d2ae8a6dee0b9a82023-02-02T05:59:53ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072020-11-01Volume 134401441259360Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical StudyPingali UAli MAGundagani SNutalapati CUsharani Pingali, Mohammed Abid Ali, Srinivas Gundagani, Chandrasekhar Nutalapati Department of Pharmacology and Therapeutics, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana 500073, IndiaCorrespondence: Usharani Pingali Email ushapingali@yahoo.comPurpose: Neem tree (Azadirachta indica) offers different bioactives ranging from pesticides to therapeutic molecules, depending on which part of the plant is used and the extraction methodology and the solvent used. This study was aimed at evaluating the safety and efficacy of a standardized aqueous extract of Azadirachta indica leaves and twigs (NEEM) on glycemic control, endothelial dysfunction, and systemic inflammation in patients with type 2 diabetes mellitus (T2DM).Methods: In this randomized, double-blind, placebo-controlled clinical study (RCT), 80 T2DM subjects, who have already been on standard metformin therapy, received either 125 mg, 250 mg, 500 mg of NEEM or placebo twice daily for 12 weeks. Postprandial blood sugar level (PPBS), fasting blood sugar level (FBS), glycosylated hemoglobin (HbA1c), insulin resistance (IR), endothelial function, oxidative stress, systemic inflammation, IL-6 and TNF-α, platelet aggregation and lipid profile were assessed. Adverse drug reactions, if any, were noted. GraphPad Prism 8 was used to perform statistical analysis.Results: NEEM at the doses of 125, 250, and 500 mg BID significantly reduced PPBS (from 194.4± 14 to 173.1± 12.8mg/dL, 192.3± 17.1 to 161.8± 9.7mg/dL, and 205.9± 7.2 to 159.3± 7.1mg/dL, respectively), FBS (from 119.2± 5.0 to 109.2± 5.7mg/dL, 115.5± 4.4 to 103.7± 4.2mg/dL, and 120.7± 4.2 to 97.3± 3.7mg/dL, respectively), HbA1c (from 6.87 ± 0.4% to 6.64 ± 0.4%, 7.52 ± 0.4% to 6.86 ± 0.3%, and 7.78 ± 0.2% to 6.26 ± 0.4%, respectively), and IR (from 4.5 ± 1.2 to 3.4 ± 0.9, 3.8 ± 1.1 to 2.5 ± 0.6, and 4.6 ± 1.3 to 2.0 ± 0.6, respectively) compared to placebo. Also, NEEM significantly improved endothelial function, decreased oxidative stress and systemic inflammation compared to placebo. The efficacy was significant with all the doses, but no effect on platelet aggregation or lipid profile was observed.Conclusion: NEEM may significantly ameliorate hyperglycemia, endothelial dysfunction, and systemic inflammation, on top of what metformin could do, in subjects with T2DM.Keywords: Azadirachta indica, neem, hyperglycemia, insulin resistance, endothelial dysfunction, type 2 diabetes, metforminhttps://www.dovepress.com/evaluation-of-the-effect-of-an-aqueous-extract-of-azadirachta-indica-n-peer-reviewed-article-DMSOazadirachta indicaneemhyperglycemiainsulin resistanceendothelial dysfunctiontype 2 diabetesmetformin.
spellingShingle Pingali U
Ali MA
Gundagani S
Nutalapati C
Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study
Diabetes, Metabolic Syndrome and Obesity
azadirachta indica
neem
hyperglycemia
insulin resistance
endothelial dysfunction
type 2 diabetes
metformin.
title Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study
title_full Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study
title_fullStr Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study
title_full_unstemmed Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study
title_short Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study
title_sort evaluation of the effect of an aqueous extract of azadirachta indica neem leaves and twigs on glycemic control endothelial dysfunction and systemic inflammation in subjects with type 2 diabetes mellitus ndash a randomized double blind placebo controlled clinical study
topic azadirachta indica
neem
hyperglycemia
insulin resistance
endothelial dysfunction
type 2 diabetes
metformin.
url https://www.dovepress.com/evaluation-of-the-effect-of-an-aqueous-extract-of-azadirachta-indica-n-peer-reviewed-article-DMSO
work_keys_str_mv AT pingaliu evaluationoftheeffectofanaqueousextractofazadirachtaindicaneemleavesandtwigsonglycemiccontrolendothelialdysfunctionandsystemicinflammationinsubjectswithtype2diabetesmellitusndasharandomizeddoubleblindplacebocontrolledclinicalstudy
AT alima evaluationoftheeffectofanaqueousextractofazadirachtaindicaneemleavesandtwigsonglycemiccontrolendothelialdysfunctionandsystemicinflammationinsubjectswithtype2diabetesmellitusndasharandomizeddoubleblindplacebocontrolledclinicalstudy
AT gundaganis evaluationoftheeffectofanaqueousextractofazadirachtaindicaneemleavesandtwigsonglycemiccontrolendothelialdysfunctionandsystemicinflammationinsubjectswithtype2diabetesmellitusndasharandomizeddoubleblindplacebocontrolledclinicalstudy
AT nutalapatic evaluationoftheeffectofanaqueousextractofazadirachtaindicaneemleavesandtwigsonglycemiccontrolendothelialdysfunctionandsystemicinflammationinsubjectswithtype2diabetesmellitusndasharandomizeddoubleblindplacebocontrolledclinicalstudy